KANATIVA INC. enters NEXIEN BIOPHARMA, INC. with 24M shares across direct and indirect positions
This filing by KANATIVA INC. establishes the baseline for all future Form 4 insider transaction reports at NEXIEN BIOPHARMA, INC..
Indirect
Filed: 5/2/2019ACC: 0001144204-19-023243
24M
Baseline shares
0.00
Direct ownership
0 positions
0.00
Derivative underlying
0 instruments
1
Security positions
24M indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned24M
Total
24M indirect24M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 24M | Indirect |
| Total | 24M | 24M indirect |
Derivative Holdings0
No derivative holdings reported